Catherine Anne Marcinkiewcz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Catherine Anne Marcinkiewcz has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Nagalakshmi Balasubramanian
Department of Neuroscience and Pharmacology, University of Iowa
9 shared publications - Louis John Kolling
Department of Neuroscience and Pharmacology University of Iowa Iowa City Iowa USA
8 shared publications Nagalakshmi Balasubramanian
Department of Neuroscience and Pharmacology University of Iowa Iowa City Iowa USA
8 shared publicationsRuixiang Wang
Department of Neuroscience and Pharmacology University of Iowa Iowa City Iowa USA
8 shared publications- Kanza M. Khan
Daemen University
6 shared publications - Ruixiang Wang
Department of Neuroscience and Pharmacology, University of Iowa
6 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (8)
Dorsal raphe tau pathology disrupts sleep‐wake orchestration and sleep architecture in a sex‐specific manner
INTRODUCTION: Sleep disturbances are frequent symptoms of Alzheimer's disease (AD), mirrored by early pathology in the dorsal raphe nucleus (DRN). Whether early DRN pathology can drive sleep disturbances, and the relative contributions of serotonin (5‐HT) and sex, has not been directly tested. METHODS: We isolate tau pathology to whole DRN (DRN Tau ), serotonin neurons of the DRN (5‐HT Tau ), or non‐serotonergic neurons of the DRN (non5HT Tau ). We use longitudinal EEG recordings, in male and female mice, to determine the contributions of DRN neuronal subtypes to sleep disruption within the context of prodromal AD. RESULTS: DRN Tau , 5‐HT Tau , and non5HT Tau disrupt sleep architecture. 5‐HT Tau and non5HT Tau further disrupt sleep‐wake orchestration and exhibit sex‐dependent alterations that coincide with changes in delta wave power. DISCUSSION: Tau‐mediated sleep dysfunction may be driven by various cellular subtypes of the DRN, are primarily sexually divergent, and may resultant in changes in 5‐HT activity and relative spectral brain wave contributions.
- 7 August 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (8)
Open AccessDorsal raphe tau pathology disrupts sleep‐wake orchestration and sleep architecture in a sex‐specific manner
INTRODUCTION: Sleep disturbances are frequent symptoms of Alzheimer's disease (AD), mirrored by early pathology in the dorsal raphe nucleus (DRN). Whether early DRN pathology can drive sleep disturbances, and the relative contributions of serotonin (5‐HT) and sex, has not been directly tested. METHODS: We isolate tau pathology to whole DRN (DRN Tau ), serotonin neurons of the DRN (5‐HT Tau ), or non‐serotonergic neurons of the DRN (non5HT Tau ). We use longitudinal EEG recordings, in male and female mice, to determine the contributions of DRN neuronal subtypes to sleep disruption within the context of prodromal AD. RESULTS: DRN Tau , 5‐HT Tau , and non5HT Tau disrupt sleep architecture. 5‐HT Tau and non5HT Tau further disrupt sleep‐wake orchestration and exhibit sex‐dependent alterations that coincide with changes in delta wave power. DISCUSSION: Tau‐mediated sleep dysfunction may be driven by various cellular subtypes of the DRN, are primarily sexually divergent, and may resultant in changes in 5‐HT activity and relative spectral brain wave contributions.
- Open Access
- 12 May 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (5) , e71317
Selective reduction of KCNA4 in vulnerable glutamatergic–serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease
INTRODUCTION: Our previous studies demonstrate that htau mice recapitulate many of the neuropsychiatric features of early Alzheimer's disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate the vulnerability of the centromedial DRN to pathologically phosphorylated tau (p‐tau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use a battery of computational, molecular, biophysical, and behavioral techniques to assess molecular changes in the centromedial DRN across preclinical and post mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion‐channel genes in the htau mouse. This is associated with increased neuronal excitability, which may promote p‐tau accumulation. At Braak II, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to p‐tau compared to 5HT‐nonglut neurons. DISCUSSION: Tau‐mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of p‐tau in Braak progression.
- 12 May 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (5) , e71317
Open AccessSelective reduction of KCNA4 in vulnerable glutamatergic–serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease
INTRODUCTION: Our previous studies demonstrate that htau mice recapitulate many of the neuropsychiatric features of early Alzheimer's disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate the vulnerability of the centromedial DRN to pathologically phosphorylated tau (p‐tau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use a battery of computational, molecular, biophysical, and behavioral techniques to assess molecular changes in the centromedial DRN across preclinical and post mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion‐channel genes in the htau mouse. This is associated with increased neuronal excitability, which may promote p‐tau accumulation. At Braak II, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to p‐tau compared to 5HT‐nonglut neurons. DISCUSSION: Tau‐mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of p‐tau in Braak progression.
- Open Access
- 10 April 2026
- Published by Elsevier in Neurobiology of Disease
- Vol. 224, 107393
Adolescent social isolation facilitates tau spread in raphe nuclei, linking depression and hyperalgesia in Alzheimer's disease
- 10 April 2026
- Published by Elsevier in Neurobiology of Disease
- Vol. 224, 107393
Open AccessAdolescent social isolation facilitates tau spread in raphe nuclei, linking depression and hyperalgesia in Alzheimer's disease
- Open Access
Adolescent Social Isolation Facilitates Tau Spread in Raphe Nuclei, Linking Depression and Hyperalgesia in Alzheimer’s Disease
Tau pathology in brainstem serotonergic circuits drives early neuropsychiatric dysfunction in Alzheimer’s disease (AD), yet mechanisms linking the exposome, particularly social stress exposures to depression and altered pain perception, remain unclear. Here, we demonstrate that adolescent social isolation, a critical psychosocial exposome factor and major trigger of depression, facilitates tau propagation in the dorsal raphe nucleus (DRN) and downstream raphe nuclei, producing both neuropsychiatric and pain-related sequelae. Tau[P301L] was transduced into the DRN of 30-day socially isolated or group housed C57BL/6J mice using AAV, with control mice receiving AAV-GFP. Four weeks post-transduction, anxiety, social behavior, and pain sensitivity were assessed, and phosphorylated tau (ptau) within the DRN and spread to the median raphe (MRN) and raphe magnus (RMg) serotonergic neurons were evaluated. Socially isolated tau[P301L] mice exhibited hyperlocomotion, anxiety-like behavior, social deficits and hyperalgesia. Histological analysis revealed elevated ptau within TPH2 neurons in the DRN and trans-synaptic tau spread to MRN and RMg, accompanied by reduced TPH2 and increased ptau at the downstream raphe nuclei. Fluorescence in situ hybridization confirmed altered expression of Slc6a4 and Tgm2 , a stress-responsive gene implicated in AD. These results indicate that DRN tau under social stress drives neuropsychiatric phenotypes, while tau spread to MRN and RMg disrupts serotonergic modulation of pain. This study provides the first evidence that adolescent stress promotes tau propagation within the raphe nuclei, linking early neuropsychiatric and pain-processing deficits to prodromal Alzheimer’s disease and identifying a critical pathway through which psychosocial exposome risk converges with tau pathology to enable early intervention.
Open AccessAdolescent Social Isolation Facilitates Tau Spread in Raphe Nuclei, Linking Depression and Hyperalgesia in Alzheimer’s Disease
Tau pathology in brainstem serotonergic circuits drives early neuropsychiatric dysfunction in Alzheimer’s disease (AD), yet mechanisms linking the exposome, particularly social stress exposures to depression and altered pain perception, remain unclear. Here, we demonstrate that adolescent social isolation, a critical psychosocial exposome factor and major trigger of depression, facilitates tau propagation in the dorsal raphe nucleus (DRN) and downstream raphe nuclei, producing both neuropsychiatric and pain-related sequelae. Tau[P301L] was transduced into the DRN of 30-day socially isolated or group housed C57BL/6J mice using AAV, with control mice receiving AAV-GFP. Four weeks post-transduction, anxiety, social behavior, and pain sensitivity were assessed, and phosphorylated tau (ptau) within the DRN and spread to the median raphe (MRN) and raphe magnus (RMg) serotonergic neurons were evaluated. Socially isolated tau[P301L] mice exhibited hyperlocomotion, anxiety-like behavior, social deficits and hyperalgesia. Histological analysis revealed elevated ptau within TPH2 neurons in the DRN and trans-synaptic tau spread to MRN and RMg, accompanied by reduced TPH2 and increased ptau at the downstream raphe nuclei. Fluorescence in situ hybridization confirmed altered expression of Slc6a4 and Tgm2 , a stress-responsive gene implicated in AD. These results indicate that DRN tau under social stress drives neuropsychiatric phenotypes, while tau spread to MRN and RMg disrupts serotonergic modulation of pain. This study provides the first evidence that adolescent stress promotes tau propagation within the raphe nuclei, linking early neuropsychiatric and pain-processing deficits to prodromal Alzheimer’s disease and identifying a critical pathway through which psychosocial exposome risk converges with tau pathology to enable early intervention.
- Open Access
Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer’s Disease
INTRODUCTION: We previously demonstrated that htau mice recapitulate many neuropsychiatric features of early Alzheimer’s disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate vulnerability of the centromedial DRN to pathologically-phosphorylated tau (pTau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use computational, molecular, biophysical, and behavioral techniques to assess the centromedial DRN across preclinical and post-mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion-channel genes in the htau mouse. 5HT/glut neurons exhibit increased excitability, which we demonstrate may dually promote pTau accumulation and the severity of depressive-like behaviors in htau mice. At Braak 2, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to pTau compared to 5HT-nonglut neurons. DISCUSSION: Tau-mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of pTau in Braak progression.
Open AccessSelective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer’s Disease
INTRODUCTION: We previously demonstrated that htau mice recapitulate many neuropsychiatric features of early Alzheimer’s disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate vulnerability of the centromedial DRN to pathologically-phosphorylated tau (pTau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use computational, molecular, biophysical, and behavioral techniques to assess the centromedial DRN across preclinical and post-mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion-channel genes in the htau mouse. 5HT/glut neurons exhibit increased excitability, which we demonstrate may dually promote pTau accumulation and the severity of depressive-like behaviors in htau mice. At Braak 2, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to pTau compared to 5HT-nonglut neurons. DISCUSSION: Tau-mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of pTau in Braak progression.
- Open Access
- 19 September 2025
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (19)
The superficial tufted and mitral cell output neurons of the mouse olfactory bulb have dual roles in insulin sensing
The olfactory bulb (OB) contains multiple, parallel projection neurons to relay the nature of a stimulus. In a mouse ex vivo slice preparation, we used patch-clamp electrophysiology to measure intrinsic properties, excitability, action potential (AP) shape, voltage-activated conductances, and neuromodulation in the newly-categorized superficial tufted cells (sTCs) compared with those of mitral cells (MCs). We propose that a marked difference in voltage-dependent current represents distinct ion channel populations that affect the kinetics of action potentials, and evokes an increase in sTC firing frequency, albeit both types of projection neurons having similar AP spiking activity. Triple-colored immunofluorescence and RNA scope were used to detect co-localization of the Kv1.3 ion channel and the insulin receptor in sTCs, with ∼73% of sTCs expressing both. The sTCs were modulated by bath application of insulin – increasing AP firing frequency by 97%, attributable to an 8% decrease in the intraburst interval, and a reduction of the latency to first spike by 37%. We conclude that there may be a range of neuromodulators of sTCs that may alter excitability and fine-tune olfactory information processing or metabolic balance.
- 19 September 2025
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (19)
Open AccessThe superficial tufted and mitral cell output neurons of the mouse olfactory bulb have dual roles in insulin sensing
The olfactory bulb (OB) contains multiple, parallel projection neurons to relay the nature of a stimulus. In a mouse ex vivo slice preparation, we used patch-clamp electrophysiology to measure intrinsic properties, excitability, action potential (AP) shape, voltage-activated conductances, and neuromodulation in the newly-categorized superficial tufted cells (sTCs) compared with those of mitral cells (MCs). We propose that a marked difference in voltage-dependent current represents distinct ion channel populations that affect the kinetics of action potentials, and evokes an increase in sTC firing frequency, albeit both types of projection neurons having similar AP spiking activity. Triple-colored immunofluorescence and RNA scope were used to detect co-localization of the Kv1.3 ion channel and the insulin receptor in sTCs, with ∼73% of sTCs expressing both. The sTCs were modulated by bath application of insulin – increasing AP firing frequency by 97%, attributable to an 8% decrease in the intraburst interval, and a reduction of the latency to first spike by 37%. We conclude that there may be a range of neuromodulators of sTCs that may alter excitability and fine-tune olfactory information processing or metabolic balance.
- Open Access
The superficial tufted and mitral cell output neurons of the mouse olfactory bulb have dual roles in insulin sensing
The olfactory bulb (OB) contains multiple, parallel projection neurons to relay the nature of a stimulus. In a mouse ex vivo slice preparation, we used patch-clamp electrophysiology to measure intrinsic properties, excitability, action potential (AP) shape, voltage-activated conductances, and neuromodulation in the newly-categorized superficial tufted cells (sTCs) compared with those of mitral cells (MCs). We propose that a marked difference in voltage-dependent current represents distinct ion channel populations that affect the kinetics of action potentials, and evokes an increase in sTC firing frequency, albeit both types of projection neurons having similar AP spiking activity. Triple-colored immunofluorescence and RNA scope were used to detect co-localization of the Kv1.3 ion channel and the insulin receptor in sTCs, with ∼73% of sTCs expressing both. The sTCs were modulated by bath application of insulin – increasing AP firing frequency by 97%, attributable to an 8% decrease in the intraburst interval, and a reduction of the latency to first spike by 37%. We conclude that there may be a range of neuromodulators of sTCs that may alter excitability and fine-tune olfactory information processing or metabolic balance. SUMMARY STATEMENT: Superficial tufted cells, as output neurons of the olfactory bulb, were electrophysiologically studied to be insulin sensitive. Brain insulin signaling represents a manner in which olfactory and metabolic circuitry are intertwined.
Open AccessThe superficial tufted and mitral cell output neurons of the mouse olfactory bulb have dual roles in insulin sensing
The olfactory bulb (OB) contains multiple, parallel projection neurons to relay the nature of a stimulus. In a mouse ex vivo slice preparation, we used patch-clamp electrophysiology to measure intrinsic properties, excitability, action potential (AP) shape, voltage-activated conductances, and neuromodulation in the newly-categorized superficial tufted cells (sTCs) compared with those of mitral cells (MCs). We propose that a marked difference in voltage-dependent current represents distinct ion channel populations that affect the kinetics of action potentials, and evokes an increase in sTC firing frequency, albeit both types of projection neurons having similar AP spiking activity. Triple-colored immunofluorescence and RNA scope were used to detect co-localization of the Kv1.3 ion channel and the insulin receptor in sTCs, with ∼73% of sTCs expressing both. The sTCs were modulated by bath application of insulin – increasing AP firing frequency by 97%, attributable to an 8% decrease in the intraburst interval, and a reduction of the latency to first spike by 37%. We conclude that there may be a range of neuromodulators of sTCs that may alter excitability and fine-tune olfactory information processing or metabolic balance. SUMMARY STATEMENT: Superficial tufted cells, as output neurons of the olfactory bulb, were electrophysiologically studied to be insulin sensitive. Brain insulin signaling represents a manner in which olfactory and metabolic circuitry are intertwined.
- Open Access
- 30 December 2024
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 45 (6)
A New Insight into the Role of CART Peptide in Serotonergic Function and Anxiety
Cocaine- and amphetamine-regulated transcript (CART) peptide has been implicated in stress-related behaviors that are regulated by central serotonergic (5-HT) systems in the dorsal raphe nucleus (DRN). Here, we aimed to investigate the interaction between CART and DRN 5-HTergic systems after initially observing CART axonal terminals in the DRN. We found that microinfusion of CART peptide (55–102) into the DRN-induced anxiogenic effects in male C57BL/6J mice, while central administration of CART reduced c-Fos in 5-HTDRN neurons. This inhibitory effect of exogenous CART on 5-HTDRN activity and local 5-HT release was also demonstrated via in vivo fiber photometry coupled with calcium and 5-HT biosensors. CART inputs to the DRN were observed in various subcortical nuclei, but only those in the centrally projecting Edinger–Westphal nucleus (EWcp) were highly responsive to stress. Chemogenetic activation of these DRN-projecting CARTEWcp neurons recapitulated the effects of intra-DRN CART infusion on anxiety-like behavior in males, but not in females, suggesting a sex-specific role for this pathway. Interestingly, CARTEWcp projections to the DRN made direct synaptic contact primarily with non-5-HT neurons, which were also found to express putative CART receptors. Furthermore, chemogenetic stimulation of this CARTEWcp→DRN pathway inhibited 5-HT neurons while increasing activity in local GABAergic neurons. In summary, this study establishes for the first time a neuromodulatory role for CARTEWcp neurons in 5-HTDRN neurotransmission and suggests that CART may drive anxiety-like behavior by promoting feedforward inhibition of 5-HT neurons.
- 30 December 2024
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 45 (6)
Open AccessA New Insight into the Role of CART Peptide in Serotonergic Function and Anxiety
Cocaine- and amphetamine-regulated transcript (CART) peptide has been implicated in stress-related behaviors that are regulated by central serotonergic (5-HT) systems in the dorsal raphe nucleus (DRN). Here, we aimed to investigate the interaction between CART and DRN 5-HTergic systems after initially observing CART axonal terminals in the DRN. We found that microinfusion of CART peptide (55–102) into the DRN-induced anxiogenic effects in male C57BL/6J mice, while central administration of CART reduced c-Fos in 5-HTDRN neurons. This inhibitory effect of exogenous CART on 5-HTDRN activity and local 5-HT release was also demonstrated via in vivo fiber photometry coupled with calcium and 5-HT biosensors. CART inputs to the DRN were observed in various subcortical nuclei, but only those in the centrally projecting Edinger–Westphal nucleus (EWcp) were highly responsive to stress. Chemogenetic activation of these DRN-projecting CARTEWcp neurons recapitulated the effects of intra-DRN CART infusion on anxiety-like behavior in males, but not in females, suggesting a sex-specific role for this pathway. Interestingly, CARTEWcp projections to the DRN made direct synaptic contact primarily with non-5-HT neurons, which were also found to express putative CART receptors. Furthermore, chemogenetic stimulation of this CARTEWcp→DRN pathway inhibited 5-HT neurons while increasing activity in local GABAergic neurons. In summary, this study establishes for the first time a neuromodulatory role for CARTEWcp neurons in 5-HTDRN neurotransmission and suggests that CART may drive anxiety-like behavior by promoting feedforward inhibition of 5-HT neurons.
- 25 November 2024
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 103 (1) , 133-148
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease
Background: Persons with Alzheimer's disease (AD) present with changes in mood, sleep, and arousal that may precede the clinical manifestation of cognitive decline. These early symptoms can be driven by changes in the serotonergic (5-HT) nuclei of the brainstem, particularly the dorsal raphe nucleus (DRN). It is unclear why all 5-HT neurons do not simultaneously develop AD pathology that progresses at the same rate. Objective: We sought to identify any underlying genetic components associated with susceptibility or resistance of 5-HT neurons to AD pathology. Methods: The Visium Spatial Gene Expression platform was used to identify transcriptomic changes across the DRN in a preclinical model of early AD, human tau-overexpressing mice (htau mice). We further used RNAscope and immunohistochemical assessment to validate findings of primary interest. Results: We find that the DRN of htau mice differentially expresses AD-related genes, including those related to kinase binding, ion channel activity, ligand-receptor interactions, and regulation of serine/threonine kinases. We further find that computational sub-clustering of the DRN is consistent with previous circuitry-driven characterizations, allowing for spatial bounding of distinct subregions within the DRN. Of these, we find the dorsolateral DRN is preferentially impacted by 5-HT neuron loss and development of tau pathology, which coincides with increased expression of the long noncoding RNA Map2k3os . Conclusions: Map2k3os may serve regulatory roles relevant for tau phosphorylation and warrants further investigation to characterize its interactions. Overall, this report demonstrates the power of large-scale spatial transcriptomics technologies, while underscoring the need for convergent-data validation to overcome their limitations.
- 25 November 2024
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 103 (1) , 133-148
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease
Background: Persons with Alzheimer's disease (AD) present with changes in mood, sleep, and arousal that may precede the clinical manifestation of cognitive decline. These early symptoms can be driven by changes in the serotonergic (5-HT) nuclei of the brainstem, particularly the dorsal raphe nucleus (DRN). It is unclear why all 5-HT neurons do not simultaneously develop AD pathology that progresses at the same rate. Objective: We sought to identify any underlying genetic components associated with susceptibility or resistance of 5-HT neurons to AD pathology. Methods: The Visium Spatial Gene Expression platform was used to identify transcriptomic changes across the DRN in a preclinical model of early AD, human tau-overexpressing mice (htau mice). We further used RNAscope and immunohistochemical assessment to validate findings of primary interest. Results: We find that the DRN of htau mice differentially expresses AD-related genes, including those related to kinase binding, ion channel activity, ligand-receptor interactions, and regulation of serine/threonine kinases. We further find that computational sub-clustering of the DRN is consistent with previous circuitry-driven characterizations, allowing for spatial bounding of distinct subregions within the DRN. Of these, we find the dorsolateral DRN is preferentially impacted by 5-HT neuron loss and development of tau pathology, which coincides with increased expression of the long noncoding RNA Map2k3os . Conclusions: Map2k3os may serve regulatory roles relevant for tau phosphorylation and warrants further investigation to characterize its interactions. Overall, this report demonstrates the power of large-scale spatial transcriptomics technologies, while underscoring the need for convergent-data validation to overcome their limitations.
- 14 August 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (2) , 532-546
Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer’s disease
Protein aggregation in brainstem nuclei is thought to occur in the early stages of Alzheimer’s disease (AD), but its specific role in driving prodromal symptoms and disease progression is largely unknown. The dorsal raphe nucleus (DRN) contains a large population of serotonin (5-hydroxytryptamine; 5-HT) neurons that regulate mood, reward-related behavior, and sleep, which are all disrupted in AD. We report here that tau pathology is present in the DRN of individuals 25–80 years old without a known history of dementia, and its prevalence was comparable to the locus coeruleus (LC). By comparison, fewer cases were positive for other pathological proteins including α-synuclein, β-amyloid, and TDP-43. To evaluate how early tau pathology impacts behavior, we overexpressed human P301L-tau in the DRN of mice and observed depressive-like behaviors and hyperactivity without deficits in spatial memory. Tau pathology was predominantly found in neurons relative to glia and colocalized with a significant proportion of Tph2-expressing neurons in the DRN. 5-HT neurons were also hyperexcitable in P301L-tauDRN mice, and there was an increase in the amplitude of excitatory post-synaptic currents (EPSCs). Moreover, astrocytic density was elevated in the DRN and accompanied by an increase in IL-1α and Frk expression, which suggests increased inflammatory signaling. Additionally, tau pathology was detected in axonal processes in the thalamus, hypothalamus, amygdala, and caudate putamen. A significant proportion of this tau pathology colocalized with the serotonin reuptake transporter (SERT), suggesting that tau may spread in an anterograde manner to regions outside the DRN. Together these results indicate that tau pathology accumulates in the DRN in a subset of individuals over 50 years and may lead to behavioral dysregulation, 5-HT neuronal dysfunction, and activation of local astrocytes which may be prodromal indicators of AD.
- 14 August 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (2) , 532-546
Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer’s disease
Protein aggregation in brainstem nuclei is thought to occur in the early stages of Alzheimer’s disease (AD), but its specific role in driving prodromal symptoms and disease progression is largely unknown. The dorsal raphe nucleus (DRN) contains a large population of serotonin (5-hydroxytryptamine; 5-HT) neurons that regulate mood, reward-related behavior, and sleep, which are all disrupted in AD. We report here that tau pathology is present in the DRN of individuals 25–80 years old without a known history of dementia, and its prevalence was comparable to the locus coeruleus (LC). By comparison, fewer cases were positive for other pathological proteins including α-synuclein, β-amyloid, and TDP-43. To evaluate how early tau pathology impacts behavior, we overexpressed human P301L-tau in the DRN of mice and observed depressive-like behaviors and hyperactivity without deficits in spatial memory. Tau pathology was predominantly found in neurons relative to glia and colocalized with a significant proportion of Tph2-expressing neurons in the DRN. 5-HT neurons were also hyperexcitable in P301L-tauDRN mice, and there was an increase in the amplitude of excitatory post-synaptic currents (EPSCs). Moreover, astrocytic density was elevated in the DRN and accompanied by an increase in IL-1α and Frk expression, which suggests increased inflammatory signaling. Additionally, tau pathology was detected in axonal processes in the thalamus, hypothalamus, amygdala, and caudate putamen. A significant proportion of this tau pathology colocalized with the serotonin reuptake transporter (SERT), suggesting that tau may spread in an anterograde manner to regions outside the DRN. Together these results indicate that tau pathology accumulates in the DRN in a subset of individuals over 50 years and may lead to behavioral dysregulation, 5-HT neuronal dysfunction, and activation of local astrocytes which may be prodromal indicators of AD.